Cerebrospinal fluid myelin basic protein-like material in acute monosymptomatic optic neuritis

Acta Neurologica Scandinavica

Volumn 94, Issue 5, 1996, Pages 303-309

  Frederiksen, J L ^a,c   Whitaker, J N ^b  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c Department of Neurology N16 ^*  (Denmark)

Author keywords

Optic neuritis

Indexed keywords

MYELIN BASIC PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE; OPTIC NERVE DISEASE; SCHOOL CHILD; VISUAL DISORDER;

EID: 0029831737     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1996.tb07070.x     Document Type: Article

References (28)

1. KURTZKE JF. Optic neuritis or multiple sclerosis. Arch Neurol 1985; 42: 704-710.
2. RIZZO JF, LESSELL S. Risk of developing multiple sclerosis after uncomplicated optic neuritis: A long-term prospective study. Neurology 1988; 38: 185-190.
3. RODRIGUEZ M, SIVA A, CROSS SA, OBRIEN PC, KURLAND LT. Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology 1995; 45: 244-250.
4. SANDBERG-WOLLHEIM M, BYNKE H, CRONQVIST S, HOLTÅS S, PLATZ P, RYDER LP. A long-term prospective study of optic neuritis: evaluation of risk factors. Ann Neurol 1990; 27: 386-393.
5. LEES MB, BROSTOFF SW. Proteins of myelin. In: Morell P, ed. Myelin. New York: Plenum Press, 1984: 197-224.
6. COHEN SR, HERNDON RM, MCKHANN GM. Myelin basic protein in cerebrospinal fluid as an indicator of active demyelination. Radioimmunoassay of myelin basic protein in spinal fluid. An index of active demyelination. N Engl J Med 1976; 295: 1454-1457.
7. WHITAKER JN. Myelin encephalitogenic protein fragments in cerebrospinal fluid of persons with multiple sclerosis. Neurology 1977; 27: 911-920.
8. WHITAKER JN, GUPTA M, SMITH OF. Epitopes of immunoreactive myelin basic protein in human cerebrospinal fluid. Ann Neurol 1986; 20: 329-336.
9. WHITAKER JN. The presence of immunoreactive myelin basic protein peptide in urine of persons with multiple sclerosis. Ann Neurol 1987; 22: 648-655.
10. WHITAKER JN, LISAK RP, BASHIR RM, et al. Immunoreactive myelin basic protein in the cerebrospinal fluid in neurological disorders. Ann Neurol 1980; 7: 58-64.
11. POSER CM, PATY DW, SCHEINBERG L, et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
12. COMPSTON DAS, BATCHELOR JR, EARL CJ. Factors influencing the risk of multiple sclerosis developing in patients with optic neuritis. Brain 1978; 101: 495-511.
13. ROSE AA, ELLISON GW, MYERS LE. Criteria for the clinical diagnosis of multiple sclerosis. Neurology 1976; 26: 20-22.
14. KELLY MA, CAVAN DA, PENNY MA, et al. The influence of HLA-DR and -DQ alleles on progression to multiple sclerosis following a clinically isolated syndrome. Hum Immunol 1993; 37: 185-191.
15. FREDERIKSEN JL, LARSSON HBW, OLESEN J. Correlation of magnetic resonance imaging and CSF findings in patients with acute monosymptomatic optic neuritis. Acta Neurol Scand 1992; 86: 317-322.
16. REIBER H, FELGENHAUER K. Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chem Acta 1987; 163: 319-328.
17. WHITAKER JN, HERMAN PK. Human myelin basic protein peptide 69-89: immunochemical features and use in immunoassays of cerebrospinal fluid. J Neuroimmunol 1988; 19: 47-57.
18. WHITAKER JN, LAYTON BA, HERMAN PK, KACHELHOFER RD, BURGARD S, BARTOLUCCI AA. Correlation of myelin basic protein-like material in cerebrospinal fluid of multiple sclerosis patients with their response to glucocorticoid treatment. Ann Neurol 1993; 33: 10-17.
19. FREDERIKSEN J, LARSSON HBW, HENRIKSEN O, OLESEN J. Magnetic resonance imaging of the brain in patients with acute monosymptomatic optic neuritis. Acta Neurol Scand 1989; 80: 512-517.
20. CHRISTIANSEN P. FREDERIKSEN JL, HENRIKSEN O, LARSSON HBW. Gd-DTPA enhanced lesions in the brain of patients with acute optic neuritis. Acta Neurol Scand 1992; 85: 141-146.
21. FREDERIKSEN JL, LARSSON HBW, OLESEN J, STIGSBY B. MR, VEP, SEP and biotesiometry suggest monosymptomatic acute optic neuritis to be a first manifestation of multiple sclerosis. Acta Neurol Scand 1991; 83: 343-350.
22. WHITAKER JN, SNYDER DS. Myelin components in the cerebrospinal fluid in diseases affecting central nervous system myelin. Clin Immunol Allergy 1982; 2: 469-482.
23. MARTINELLI V, FILIPPI CG, POGGI M, et al. Paraclinical tests in acute-onset optic neuritis: basal data and results of a short follow-up. Acta Neurol Scand 1991; 84: 231-236.
24. WHITAKER JN, BASHIR RM, CHOU C-H, KIBLER RF. Antigenic features of myelin basic protein-like material in cerebrospinal fluid. J Immunol 1980; 124: 1148-1153.
25. COHEN SR, BROOKS BR, HERNDON RM, MCKHANN GM. A diagnostic index of active demyelination: myelin basic protein in cerebrospinal fluid. Ann Neurol 1980; 8: 25-31.
26. PAVAROTTI V, MERELLI E, DE PALMA M, BETTELLI G, FAGLIONI P. Myelin basic protein in the CSF of patients with multiple sclerosis, optic neuritis and various neurological diseases. Acta Neurol Belg 1986; 86: 311-316.
27. BIBER A, ENGLERT D, DOMMASCH D, HEMPEL K. Myelin basic protein in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. J Neurol 1981; 225: 231-236.
28. WARREN KG, CATZ I, MCPHERSON TA. CSF myelin basic protein levels in acute optic neuritis and multiple sclerosis. Can J Neurol Sci 1983; 10: 235-238.